Ocugen, Inc.
OCGN • NASDAQ
Ocugen, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Shankar Musunuri, with a market cap of $613.2M.
Market Cap$613.2M
Employees84.0
CEOShankar Musunuri
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 8, 2026 · In 3 weeksQ1 2026
Financials
Ocugen, Inc. FAQ
Common questions about Ocugen, Inc.
Ocugen, Inc. is scheduled to report earnings for Q1 2026 on May 8, 2026. Analysts estimate revenue of $694.9K.
Ocugen, Inc. has approximately 84 employees.